(Q36538716)

14 August 2017

Multilaboratory testing of antifungal combinations against a quality control isolate of Candida krusei (English)

1 reference

14 August 2017

0 references

Candida krusei

1 reference

9

Michael A Pfaller

1 reference

14 August 2017

8

Shawn A Messer

1 reference

14 August 2017

Beth A Arthington-Skaggs

11

object named as

Beth A Arthington-Skaggs

1 reference

14 August 2017

15

Thomas J Walsh

1 reference

14 August 2017

Luis L Ostrosky-Zeichner

7

object named as

Luis Ostrosky-Zeichner

1 reference

14 August 2017

6

Cindy Knapp

1 reference

14 August 2017

Vishnu Chaturvedi

1

1 reference

14 August 2017

Rama Ramani

2

1 reference

14 August 2017

Mahmoud A Ghannoum

3

1 reference

14 August 2017

Scott B Killian

4

1 reference

14 August 2017

Nicole Holliday

5

1 reference

14 August 2017

Naureen J Iqbal

10

1 reference

14 August 2017

Jose A Vazquez

12

1 reference

14 August 2017

Tin Sein

13

1 reference

14 August 2017

John H Rex

14

1 reference

14 August 2017

language of work or name

English

0 references

publication date

28 January 2008

1 reference

14 August 2017

3

1 reference

Antimicrobial Agents and Chemotherapy

inferred from page(s)

published in

1 reference

14 August 2017

52

1 reference

14 August 2017

4

1 reference

14 August 2017

1500-1502

1 reference

Role of antifungal susceptibility testing in patient management

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2292538

New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2292538

Clinical efficacy of new antifungal agents

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2292538

Combination therapy of disseminated coccidioidomycosis with caspofungin and fluconazole

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2292538

Combinations of antifungal agents in therapy--what value are they?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2292538

Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2292538

Influence of test conditions on antifungal time-kill curve results: proposal for standardized methods

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2292538

Synergistic activities of fluconazole and voriconazole with terbinafine against four Candida species determined by checkerboard, time-kill, and Etest methods

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2292538

International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2292538

Assessing in vitro combinations of antifungal drugs against yeasts and filamentous fungi: comparison of different drug interaction models.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2292538

A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2292538

Antifungal activities of fluconazole, caspofungin (MK0991), and anidulafungin (LY 303366) alone and in combination against Candida spp. and Crytococcus neoformans via time-kill methods

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2292538

Comparison of Etest, chequerboard dilution and time-kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2292538

Resistant Microascus cirrosus pneumonia can be treated with a combination of surgery, multiple anti-fungal agents and a growth factor

21 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18227180

12 December 2020

inferred from PubMed ID database lookup

Synergy, antagonism, and what the chequerboard puts between them

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18227180

12 December 2020

inferred from PubMed ID database lookup

Combination antifungal therapy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18227180

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1128/AAC.00574-07

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

18227180

1 reference